Park Avenue Securities LLC grew its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 31.4% during the ...

The sellers never planned on owning the 30.7-acre property in Lyme, but bought it after a boat deal fell through. Now it’s ...

Morgan Stanley has recently raised Gilead Sciences Inc (GILD) stock rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Situated in Foster City, California, Gilead Sciences, Inc. (GILD) is a top biopharmaceutical company specializing in the ...

The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs ...

Poor mental health was increasingly prevalent from 2011 to 2022, with inequities discernible by age, sex, and racial and ...

Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on Keros Therapeutics (KROS – Research Report) today and set a price target of ...

About two and a half years after originating the role of chief commercial officer at Arvinas, John Northcott is leaving his ...

In a report released yesterday, Jasper Hellweg from Argus Research maintained a Buy rating on Novo Nordisk (NVO – Research Report). The ...

A man was carjacked while pumping gas in the middle of the day, and now police in Huntersville are searching for the suspect.

ServiceNow stock is the IBD Stock of the Day ahead of the enterprise software maker's fourth quarter earnings report.